Validating Deep Models for Alzheimer's 18F-FDG PET Diagnosis Across Populations: A Study with Latin American Data
Deep learning models have shown strong performance in diagnosing Alzheimer's disease (AD) using neuroimaging data, particularly 18F-FDG PET scans, with training datasets largely composed of North American cohorts such as those in the Alzheimer's Disease Neuroimaging Initiative (ADNI). However, their generalization to underrepresented populations remains underexplored. In this study, we benchmark convolutional and Transformer-based models on the ADNI dataset and assess their generalization performance on a novel Latin American clinical cohort from the FLENI Institute in Buenos Aires, Argentina. We show that while all models achieve high AUCs on ADNI (up to .96, .97), their performance drops substantially on FLENI (down to .82, .80, respectively), revealing a significant domain shift. The tested architectures demonstrated similar performance, calling into question the supposed advantages of transformers for this specific task. Through ablation studies, we identify per-image normalization and a correct sampling selection as key factors for generalization. Occlusion sensitivity analysis further reveals that models trained on ADNI, generally attend to canonical hypometabolic regions for the AD class, but focus becomes unclear for the other classes and for FLENI scans. These findings highlight the need for population-aware validation of diagnostic AI models and motivate future work on domain adaptation and cohort diversification.
Code (0)
등록된 구현이 없습니다.
Tasks
Domain AdaptationSimilar Papers 제목 키워드 기반
3D Grid-Attention Networks for Interpretable Age and Alzheimer's Disease Prediction from Structural MRI
We propose an interpretable 3D Grid-Attention deep neural network that can accurately predict a person's age and whether they have Alzheimer's disease (AD) from a structural brain MRI scan. Building on a 3D convolutional…
Disease PredictionAD-CARE: A Guideline-grounded, Modality-agnostic LLM Agent for Real-world Alzheimer's Disease Diagnosis with Multi-cohort Assessment, Fairness Analysis, and Reader Study
Alzheimer's disease (AD) is a growing global health challenge as populations age, and timely, accurate diagnosis is essential to reduce individual and societal burden. However, real-world AD assessment is hampered by inc…
Temporal Subtyping of Alzheimer's Disease Using Medical Conditions Preceding Alzheimer's Disease Onset in Electronic Health Records
Subtyping of Alzheimer's disease (AD) can facilitate diagnosis, treatment, prognosis and disease management. It can also support the testing of new prevention and treatment strategies through clinical trials. In this stu…
ClusteringManagementPrognosisGraph-Based Biomarker Discovery and Interpretation for Alzheimer's Disease
Early diagnosis and discovery of therapeutic drug targets are crucial objectives for the effective management of Alzheimer's Disease (AD). Current approaches for AD diagnosis and treatment planning are based on radiologi…
DiagnosticDrug DiscoveryManagementA Machine Learning Approach to Analyze the Effects of Alzheimer's Disease on Handwriting through Lognormal Features
Alzheimer's disease is one of the most incisive illnesses among the neurodegenerative ones, and it causes a progressive decline in cognitive abilities that, in the worst cases, becomes severe enough to interfere with dai…